Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Camurus AB

Market Cap 32.25B 3.32B 2.92B 2.69B 2.51B 4.71B 314B 4.79B 12.49B 154B 12.46B 12.19B 536B P/E 2026 *
36.5x
P/E 2027 * 19x
Enterprise Value 27.94B 2.87B 2.53B 2.33B 2.18B 4.08B 272B 4.15B 10.82B 134B 10.79B 10.56B 464B EV / Sales 2026 *
9.93x
EV / Sales 2027 * 6.35x
Free-Float
64.67%
Yield 2026 *
-
Yield 2027 * -
1 day-3.57%
1 week-1.73%
Current month-14.69%
1 month-14.69%
3 months-1.82%
6 months-15.92%
Current year-19.55%
1 week 54
Extreme 54
54
1 month 54
Extreme 54
59.7
Current year 54
Extreme 54
71
1 year 54
Extreme 54
71
3 years 46.15
Extreme 46.15
71.07
5 years 21.81
Extreme 21.81
71.07
10 years 7.48
Extreme 7.48
71.07
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Change 5-day change 1-year change 3-year change Capi.($)
-3.57%-1.73% - - 3.32B
+0.45%-1.37%+43.66%+141.28% 987B
+3.37%+1.66%+58.00%+44.48% 576B
+2.07%+5.52%+27.75%+72.72% 415B
+2.10%-1.30%+22.76%+15.66% 320B
+0.14%+1.25%+32.02%+20.79% 278B
+0.10%+2.25%+29.66%+39.14% 279B
+0.02%+8.47%-31.63%-42.37% 208B
+0.66%-0.24%+27.37%+52.79% 187B
+0.14%-1.71%+17.76%+61.42% 155B
Average +0.52%+1.51%+25.26%+45.10% 378.36B
Weighted average by Cap. +1.18%+0.73%+33.41%+66.83%

Financials

2026 *2027 *
Net sales 2.81B 290M 254M 234M 219M 411M 27.43B 418M 1.09B 13.46B 1.09B 1.06B 46.77B 4.15B 427M 376M 346M 324M 607M 40.49B 617M 1.61B 19.87B 1.6B 1.57B 69.05B
Net income 879M 90.41M 79.43M 73.19M 68.51M 128M 8.56B 131M 340M 4.2B 339M 332M 14.61B 1.69B 174M 153M 141M 132M 247M 16.46B 251M 654M 8.07B 652M 638M 28.06B
Net Debt -4.31B -443M -390M -359M -336M -630M -42.01B -640M -1.67B -20.61B -1.66B -1.63B -71.64B -5.88B -605M -532M -490M -459M -860M -57.35B -874M -2.28B -28.14B -2.27B -2.22B -97.79B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
26-06-18 US$54.00 -3.57% 1,029
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
542.00SEK
Average target price
771.38SEK
Spread / Average Target
+42.32%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!